Literature DB >> 11564535

Morphological and functional analysis of an incomplete CNS fiber tract lesion: graded crush of the rat optic nerve.

N Klöcker1, M Zerfowski, N C Gellrich, M Bähr.   

Abstract

Fiber tract lesions in the central nervous system (CNS) often induce delayed retrograde neuronal degeneration, a phenomenon that represents an important therapeutic challenge in clinical neurotraumatology. In the present study, we report an in vivo trauma model of graded axonal lesion of CNS neurons. Controlled by a newtonmeter device, we induced retrograde degeneration of adult rat retinal ganglion cells (RGCs) by graded crush of the optic nerve. The extent of secondary RGC death increased linearly with the applied crush force. Moreover, visually evoked potentials were used to characterize the consequences of controlled optic nerve lesion on the functional integrity of the visual projection. The presented model of fiber tract lesion closely resembles the clinical conditions of traumatic brain injury and could prove useful to screen for neuroprotective drugs based on both a morphological and functional read-out.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11564535     DOI: 10.1016/s0165-0270(01)00435-6

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  10 in total

1.  Correlation between retinal ganglion cell loss and nerve crush force-impulse established with instrumented tweezers in mice.

Authors:  Xiaorong Liu; Liang Feng; Ishan Shinde; James D Cole; John B Troy; Laxman Saggere
Journal:  Neurol Res       Date:  2020-02-26       Impact factor: 2.448

Review 2.  Inducible rodent models of glaucoma.

Authors:  Iok-Hou Pang; Abbot F Clark
Journal:  Prog Retin Eye Res       Date:  2019-09-23       Impact factor: 21.198

3.  Differential induction of c-Fos and c-Jun in the lateral geniculate nucleus of rats following unilateral optic nerve injury with contralateral retinal blockade.

Authors:  Yi Dai; Xinghuai Sun; Qian Chen
Journal:  Exp Brain Res       Date:  2008-10-15       Impact factor: 1.972

4.  Changes in ocular aquaporin expression following optic nerve crush.

Authors:  Adnan Dibas; Hidehiro Oku; Masayuki Fukuhara; Takuji Kurimoto; Tsunehiko Ikeda; Rajkumar V Patil; Najam A Sharif; Thomas Yorio
Journal:  Mol Vis       Date:  2010-03-03       Impact factor: 2.367

5.  A novel animal model of partial optic nerve transection established using an optic nerve quantitative amputator.

Authors:  Xu Wang; Ying Li; Yan He; Hong-Sheng Liang; En-Zhong Liu
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

6.  Positive effects of bFGF modified rat amniotic epithelial cells transplantation on transected rat optic nerve.

Authors:  Jia-Xin Xie; Yu Feng; Jian-Min Yuan; Zhen-Dong You; Hai-Yan Lin; Chang-Lin Lu; Jia-Jun Xu
Journal:  PLoS One       Date:  2015-03-03       Impact factor: 3.240

7.  A standardized method to create peripheral nerve injury in dogs using an automatic non-serrated forceps.

Authors:  Xuhui Wang; Liang Wan; Xinyuan Li; Youqiang Meng; Ningxi Zhu; Min Yang; Baohui Feng; Wenchuan Zhang; Shugan Zhu; Shiting Li
Journal:  Neural Regen Res       Date:  2012-11-15       Impact factor: 5.135

8.  Optic nerve crush induces spatial and temporal gene expression patterns in retina and optic nerve of BALB/cJ mice.

Authors:  Tasneem P Sharma; Colleen M McDowell; Yang Liu; Alex H Wagner; David Thole; Benjamin P Faga; Robert J Wordinger; Terry A Braun; Abbot F Clark
Journal:  Mol Neurodegener       Date:  2014-04-27       Impact factor: 14.195

9.  Effect of alpha lipoic acid on retinal ganglion cell survival in an optic nerve crush model.

Authors:  Ruixing Liu; Yanling Wang; Mingliang Pu; Jie Gao
Journal:  Mol Vis       Date:  2016-09-23       Impact factor: 2.367

10.  Inflammatory stimulation preserves physiological properties of retinal ganglion cells after optic nerve injury.

Authors:  Henrike Stutzki; Christian Leibig; Anastasia Andreadaki; Dietmar Fischer; Günther Zeck
Journal:  Front Cell Neurosci       Date:  2014-02-12       Impact factor: 5.505

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.